MTVA MetaVia Inc.

Price (delayed)

$1.63

Market cap

$10.74M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.63

Enterprise value

-$1.72M

?
Relative Growth: Rel. Growth: 18
Relative Strength: Rel. Strength: 12
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 6

Gemphire is a clinical-stage biopharmaceutical company that is committed to helping patients with cardiometabolic disorders, including dyslipidemia and NASH. The Company is focused on providing new treatment options for cardiometabolic ...

Highlights
The EPS has soared by 78% YoY and by 35% QoQ
The debt has soared by 81% YoY but it fell by 9% QoQ
The company's net income rose by 22% YoY but it fell by 10% QoQ
The equity has declined by 29% year-on-year and by 25% since the previous quarter
The quick ratio has declined by 25% since the previous quarter

Key stats

What are the main financial stats of MTVA

MTVA stock price

How has the MetaVia stock price performed over time
Intraday
-2.98%
1 week
5.84%
1 month
11.64%
1 year
-85.61%
YTD
-80.64%
QTD
13.99%

Financial performance

How have MetaVia's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$14.93M
Net income
-$14.45M
Gross margin
N/A
Net margin
N/A
MTVA's operating income is up by 25% YoY but it is down by 8% from the previous quarter
The company's net income rose by 22% YoY but it fell by 10% QoQ

Price vs fundamentals

How does MTVA's price correlate with its fundamentals

Growth

What is MetaVia's growth rate over time

Valuation

What is MetaVia stock price valuation
P/E
N/A
P/B
1.23
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has soared by 78% YoY and by 35% QoQ
The P/B is 45% below the 5-year quarterly average of 2.3 and 42% below the last 4 quarters average of 2.2
The equity has declined by 29% year-on-year and by 25% since the previous quarter

Efficiency

How efficient is MetaVia business performance
The ROE fell by 21% QoQ
The ROA has contracted by 21% from the previous quarter

Dividends

What is MTVA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MTVA.

Financial health

How did MetaVia financials performed over time
MetaVia's total assets is 106% higher than its total liabilities
MetaVia's total assets has decreased by 28% YoY and by 8% QoQ
The total liabilities has declined by 27% year-on-year but it rose by 21% since the previous quarter
The debt is 97% lower than the equity
MTVA's debt to equity has surged by 200% year-on-year and by 50% since the previous quarter
The debt has soared by 81% YoY but it fell by 9% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.